Glossary of terms related to multiple sclerosis (MS)*
Having rapid onset, usually with recovery; not chronic or long-lasting.
Protein produced by certain cells of the immune system, which is produced in response to bacteria, viruses, and other types of foreign antigens.
Any substance that triggers the immune system to produce an antibody; generally refers to infections or toxic substances.
The incoordination and unsteadiness that results from the brain's failure to regulate the body's posture and the strength and direction of limb movements. Ataxia is most often caused by disease activity in the cerebellum.
A process in which the body's immune system causes illness by mistakenly attacking healthy cells, organs, or tissues in the body that are essential for good health. Multiple sclerosis is believed to be an autoimmune disease, along with systemic lupus erythematosus, rheumatoid arthritis, scleroderma, and many others. The precise origin and pathophysiologic processes of these diseases are unknown.
Autonomic nervous system
The part of the nervous system that regulates involuntary vital functions, including the activity of the cardiac (heart) muscle, smooth muscles (eg, of the gut), and glands. The autonomic nervous system has 2 divisions: the sympathetic nervous system accelerates heart rate, constricts blood vessels, and raises blood pressure; the parasympathetic nervous system slows heart rate, increases intestinal and gland activity, and relaxes sphincter muscles.
A paralysis of the facial nerve (usually on one side of the face), which can occur as a consequence of MS, viral infection, or other infections. It has acute onset and can be transient or permanent.
Central nervous system (CNS)
The part of the nervous system that includes the brain, optic nerves, and spinal cord. The nerves that leave the spinal cord and go to the rest of the body make up the peripheral nervous system.
Cerebrospinal fluid (CSF)
A watery, colorless, clear fluid that bathes and protects the brain and spinal cord. The composition of this fluid can be altered by a variety of diseases. Certain changes in CSF that are characteristic of MS can be detected with a lumbar puncture (spinal tap), a test sometimes used to help make the MS diagnosis.
Of long duration, not acute; a term often used to describe a disease that shows gradual worsening.
Clinically isolated syndrome (CIS)
A first neurological event that is suggestive of demyelination, accompanied by multiple, clinically "silent" (asymptomatic) lesions on MRI that are typical of MS. Individuals with CIS are at high risk for developing clinically definite MS.
A loss of myelin in the white matter of the central nervous system.
Distorted or unpleasant sensations experienced by a person when the skin is touched. These sensations are typically caused by abnormalities in the sensory pathways in the brain and spinal cord.
A disturbance of coordination caused by lesions in the cerebellum. A tendency to over- or underestimate the extent of motion needed to place an arm or leg in a certain position (eg, overreaching for an object).
Difficulty in swallowing. It is a neurologic or neuromuscular symptom that may result in aspiration (whereby food or saliva enters the airway), slow swallowing (possibly resulting in inadequate nutrition), or both.
Evoked potentials (EPs)
EP tests are a useful way of confirming the diagnosis of MS. These tests measure the brain's electrical response to sensory input (eg, sound, light, or touch) and are done by placing wires on specific areas of the scalp. The doctor then compares the patient's response times with normal response times. If there is a difference in response time, this can show that there are lesions along specific nerve pathways, even when there are no symptoms. Visual EPs are considered the most useful in MS.
As a test of dysmetria and intention tremor, the person is asked, with eyes closed, to touch the tip of the nose with the tip of the index finger. This test is part of the standard neurologic exam.
Weakness of one side of the body, including one arm and one leg.
Paralysis of one side of the body, including one arm and one leg.
Tremor that develops or becomes more pronounced as a person tries to grasp or reach for an object, or tries to move a hand or foot to a precise spot. Often the tremor only occurs during physical movement. Intention tremor is the most common and can be the most disabling form of tremor in people with MS.
In MS, a form of treatment that slows or inhibits the body's natural immune responses, including those directed against the body's own tissues.
An abnormal sensation of electricity or "pins and needles" going down the spine into the arms and legs that occurs when the neck is bent forward so that the chin touches the chest.
A soft, white coating of nerve fibers in the central nervous system, which may be found in higher-than-normal concentrations in the cerebrospinal fluid of individuals with MS and other diseases that damage myelin.
An x-ray procedure by which the spinal canal and the spinal cord can be visualized. It is performed in conjunction with a lumbar puncture and injection of a special x-ray contrast material into the spinal cord.
Includes all of the neural structures in the body: the central nervous system consists of the brain, spinal cord and optic nerves; the peripheral nervous system consists of the nerve roots, nerve plexi, and nerves throughout the body.
Physician who specializes in the diagnosis and treatment of conditions related to the nervous system.
Continuous, involuntary, and chaotic eye movements that result in a visual disturbance in which objects appear to be jumping or bouncing.
A weakness, but not total paralysis, of the lower extremities/legs.
An area of inflamed or demyelinated central nervous system tissue. A plaque, or lesion, which can vary from a few millimeters to a few centimeters in diameter, generally contains inflammatory cells and other cells that contribute to brain inflammation.
An inability to stand upright due to disturbed coordination of the involved muscles, which results in swaying and a tendency to fall in one or another direction.
Lightning-like acute pain in the face caused by demyelination of nerve fibers at the site where the sensory (trigeminal) nerve root for that part of the face enters the brainstem.
A dizzying sensation of the environment spinning, often accompanied by nausea and vomiting.
The part of the brain that contains myelinated nerve fibers, and therefore appears white, in contrast to the cortex of the brain, which contains nerve cell bodies and appears gray.
*These glossary terms are provided here as an educational resource for multiple sclerosis patients and are not necessarily related to treatment with Glatopa. Please consult with your healthcare professional if you have any questions about your condition on your treatment.
Glatopa® (glatiramer acetate injection) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Important Safety Information
Do not take Glatopa® if you are allergic to glatiramer acetate, mannitol, or any of the ingredients in Glatopa.
Some patients report a short-term reaction right after or within minutes after injecting glatiramer acetate. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heartbeat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your healthcare provider right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your healthcare provider tells you to begin again.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your healthcare provider if you experience chest pain that lasts for a long time or feels very intense.
A permanent indentation under the skin (lipoatrophy) or, rarely, necrosis at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your healthcare provider of any skin changes.
Liver problems, including liver failure, can occur with Glatopa. Call your healthcare provider right away if you have symptoms, such as: nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, sleepiness.
The most common side effects in studies of glatiramer acetate injection are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of glatiramer acetate. For a complete list, ask your healthcare provider or pharmacist. Tell your healthcare provider about any side effects you have while taking Glatopa.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information for Glatopa.